Knife-wielding man fatally shot by police in West Virginia hospital emergency room
CHARLESTON, W.Va. — Police in West Virginia shot and killed a knife-wielding man in a hospital emergency room after he attacked an employee early Friday, authorities said.
The shooting occurred around 1:45 a.m. at Charleston Area Medical Center's General Hospital in Charleston, Police Chief Scott Dempsey said at a news conference.
The suspect walked into the emergency room shortly after midnight seeking treatment for an undetermined injury. He began acting erratically, yelled and became aggressive toward others. The man eventually came out of a bathroom with a knife, lunged at others, moved furniture and sprayed a fire extinguisher, Dempsey said.
Others in the emergency room, 'were trying to just de-escalate the situation, but it obviously was not working. And at some point they had to protect theirself by getting to safety,' Dempsey said.
When an arriving officer ordered the suspect to drop the knife, the man went into an elevator and began attacking an employee before the officer shot the suspect. The suspect fell to the floor and later was pronounced dead. The employee was not injured, the chief said.
The suspect's name was withheld pending notification of relatives.
The emergency room was locked down for about two hours afterward, hospital spokesperson Dale Witte said in a statement.
The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
3 hours ago
- CTV News
Melania Trump demands Hunter Biden retract ‘extremely salacious' Epstein comments
President Donald Trump, center right, and first lady Melania Trump walk, center left, walk with Jason Hing, chief deputy of emergency services at the Los Angles Fire Department, left, and Capt. Jeff Brown, Chief of Station 69, as they tour the Pacific Palisades neighborhood affected by recent wildfires in Los Angeles, Jan. 24, 2025. (AP Photo/Mark Schiefelbein, File) WASHINGTON — First lady Melania Trump demanded that Hunter Biden retract comments linking her to sex trafficker Jeffrey Epstein and threatened to sue if he does not. Trump takes issue with two comments Biden, son of former President Joe Biden, made in an interview this month with British journalist Andrew Callaghan. He alleged that Epstein introduced the first lady to now-U.S. President Donald Trump. The statements are false, defamatory and 'extremely salacious,' Melania Trump's lawyer, Alejandro Brito, wrote in a letter to Biden. Biden's remarks were widely disseminated on social media and reported by media outlets around the world, causing the first lady 'to suffer overwhelming financial and reputational harm,' he wrote. Biden made the Epstein comments during a sprawling interview in which he lashed out at 'elites' and others in the Democratic Party he says undermined his father before he dropped out of last year's presidential campaign. 'Epstein introduced Melania to Trump. The connections are, like, so wide and deep,' Biden said in one of the comments Trump disputes. Biden attributed the claim to author Michael Wolff, whom Trump disparaged in June as a 'third rate reporter.' He has accused Wolff of making up stories to sell books. The first lady's threats echo a favoured strategy of her husband, who has aggressively used litigation to go after critics. Public figures like the Trumps face a high bar to succeed in a defamation lawsuit. The president and first lady have long said they were introduced by Paolo Zampolli, a modeling agent, at a New York Fashion Week party in 1998. The letter is dated Aug. 6 and was first reported Wednesday by Fox News Digital. Abbe Lowell, a lawyer who has represented Biden in his criminal cases and to whom Brito's letter is addressed, did not immediately respond to a request for comment late Wednesday. ___ Jonathan J. Cooper, The Associated Press
National Post
3 hours ago
- National Post
Ohio's gambling oversight agency working with MLB on probe involving Guardians
COLUMBUS, Ohio — The agency that oversees sports gambling in Ohio says it is working with Major League Baseball on the investigation of Cleveland Guardians pitchers Emmanuel Clase and Luis Ortiz, but had no further comment. Article content The Ohio Casino Control Commission said it was notified on June 30 by an Ohio licensed sportsbook of suspicious wagering activity on Guardians wagering events before also being contacted by MLB. Article content Article content Article content The commission conducted an independent investigation in 2023 when there was suspicious wagering activity on the University of Alabama's baseball team. Article content The commission's next meeting is on Aug. 20. Gov. Mike DeWine has asked the commission to ban player-specific micro bets. Ortiz is being investigated for two pitches thrown by the right-hander that received higher activity than usual during his starts at Seattle on June 15 and against St. Louis on June 27. The gambling activity on the pitches was flagged by a betting-integrity firm and forwarded to MLB. Article content 'The evidence that prop betting is harming athletics in Ohio is reaching critical mass. First, there were threats on Ohio athletes, and now two high-profile Ohio professional athletes have been suspended by Major League Baseball as part of a 'sports betting investigation,'' DeWine said in a statement on July 31. 'The harm to athletes and the integrity of the game is clear, and the benefits are not worth the harm. The prop betting experiment in this country has failed badly.' Article content
Globe and Mail
3 hours ago
- Globe and Mail
Orthopedic Devices Market Poised for 4.78% CAGR Growth Through 2030: FDA Approvals, Breakthrough Device Designation and AI-Enabled Devices Reshape the Market
DelveInsight projects the orthopedic devices market to grow from USD 44.09B in 2023 to USD 57.79B by 2030 at a 4.78% CAGR, driven by rising musculoskeletal disorders and innovation. Key players include Stryker, Zimmer Biomet, Johnson & Johnson, Medtronic, Maxx Orthopedics, Hyalex Orthopaedics, and OrthoPreserve. FDA approvals, AI-enabled devices, and breakthrough technologies like OSCAR PRO, AccelStim, and UNID systems propel market expansion. DelveInsight's ' Orthopedic Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2030 ' report delivers a comprehensive analysis of the Orthopedic Devices market globally. Key Takeaways Market size projection: As per DelveInsight's analysis, the total market size of Orthopedic Devices globally is expected to surge from USD 44.09 billion in 2023 to USD 57.79 billion by 2030. Patient population data: The report provides the total musculoskeletal disease potential pool, highlighting that 1.71 billion people suffer from conditions such as osteoarthritis, osteoporosis, and rheumatoid arthritis globally, with 528 million osteoarthritis and 18 million rheumatoid arthritis cases in 2019, plus ~300K people living with spinal cord injuries. Key orthopedic device companies: Leading orthopedic device companies, such as Stryker Corporation, Zimmer Biomet, Johnson & Johnson, and Medtronic PLC Pipeline assets: Some of the key orthopedic device innovations in the pipeline include the OSCAR PRO ultrasonic arthroplasty revision system, AccelStim Bone Growth Stimulator, AxSOS Ankle Fusion System, Insignia Hip stem, and AI-enabled UNID spinal fusion devices. In August 2025, the FDA approved the SetPoint System, a neuroimmune modulation device for treating adults with moderately to severely active rheumatoid arthritis. In June 2025, Maxx Orthopedics received FDA 510(k) clearance for their Freedom® Total Knee System Titanium Tibial Base Plate. This approval introduces a new material option, transitioning from CoCrMo to Wrought Titanium-6Aluminium-4Vanadium ELI Alloy (Ti6Al4V ELI) for the tibial base plate component. In May 2025, Hyalex Orthopaedics secured FDA approval of its supplemental Investigational Device Exemption (IDE) application for the Freestyle Knee Implant. In March 2025, Johnson & Johnson MedTech showcased major advances at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting. Building on their momentum from the previous year's 18 FDA 510(k) clearances and 45 global product launches, the company introduced cutting-edge implants, advanced techniques, and data-driven technologies across joint reconstruction, trauma, extremities, and spine specialties. January 2025: OrthoPreserve received Breakthrough Device Designation and enrolled in the FDA TAP program for its Defender meniscus replacement implant. Discover recent advancements in the Orthopedic Devices landscape @ Orthopedic Devices Recent Developments. Orthopedic Devices Market Dynamics The global orthopedic devices market reached USD 44.09 billion in 2023 and is expanding at a compound annual growth rate (CAGR) of 4.78%, projected to attain USD 57.79 billion by 2030. This growth reflects both demographic pressures, an aging population with 54.1 million U.S. residents aged 65 or older as of 2019, and the rising incidence of bone and joint disorders. Musculoskeletal conditions are the leading contributors to disability worldwide, driving substantial demand for implants, supports, and related devices. Orthopedic devices market drivers include the increasing prevalence of osteoarthritis (528 million cases) and osteoporosis, occupational and non-occupational injuries, and technological innovation in implant materials and design. Innovations such as biocompatible titanium constructs and AI-integrated hardware are elevating clinical outcomes and reducing complication rates. For instance, ultrasonic arthroplasty tools like OSCAR PRO facilitate minimally invasive revisions, while AccelStim enhances fracture healing through targeted bone stimulation. The advances in biomechanics, materials science, and regenerative engineering underpin device performance. Titanium interbody cages, porous polymer composites, and smart sensors are enabling load-sharing implants with real-time monitoring. Mechanistically, bone growth stimulators exploit electromagnetic or ultrasonic energy to upregulate osteoblast activity and accelerate fusion. The orthopedic devices innovation and development is robust, with numerous devices in various trial phases. OrthoPreserve's Defender meniscus replacement is in breakthrough designation pathways, and Medtronic's UNID system illustrates the integration of AI in device-guided spinal fusion. Concurrently, Stryker and Zimmer Biomet are conducting post-market surveillance studies to refine long-term safety profiles. The orthopedic devices competitive landscape features diversified strategies: major players invest in in-licensing and partnerships to expand portfolios, while mid-sized innovators focus on niche applications such as ankle and wrist arthrodesis. Strategic M&A activity is anticipated as companies seek to consolidate capabilities in biologics-enabled devices. The orthopedic devices market barriers include regulatory hurdles for novel biomaterials, reimbursement constraints, and potential competition from non-implant therapies (e.g., biologics, cell therapy). However, opportunities abound in emerging markets, tele-enabled surgery, and personalized implant design via 3D printing. The future outlook projects continued growth driven by demographic trends, rising healthcare expenditure, and sustained R&D investment in next-generation orthopedic solutions. Download the Orthopedic Devices Market report to understand which factors are driving the therapeutic market @ Orthopedic Devices Market Trends. Orthopedic Devices Potential Patient Pool Musculoskeletal disorders impact 1.71 billion individuals globally, with 528 million suffering from osteoarthritis and 18 million affected by rheumatoid arthritis as of 2019. Spinal cord injuries afflict approximately 296,000 patients worldwide, with 17,900 new cases annually. DelveInsight's epidemiology segmentation reveals that osteoarthritis accounts for the largest share of years lived with disability, followed by rheumatoid arthritis. The total orthopedic devices eligible patient pools encompass those requiring surgical implants or supportive orthoses, with treated cases driven by healthcare access and device availability. Geographic analysis indicates North America leads market adoption, followed by Europe and Asia-Pacific, where aging demographics and expanding surgical capacity fuel device uptake. Forecasting through 2030 anticipates rising incident cases and an expanding treated cohort as minimally invasive and outpatient surgical centers proliferate. Discover evolving trends in the Orthopedic Devices patient pool forecasts @ Orthopedic Devices Patient Pool Analysis. Key Orthopedic Devices Companies and Competitive Landscape The orthopedic devices sector is anchored by established players and dynamic innovators. Current treatment options range from prophylactic supports (braces, orthoses) to complex implants (total joint prostheses, spinal fusion systems). Stryker Corporation leads with its Insignia Hip stem and AxSOS Ankle Fusion System, leveraging titanium design and updated screw arrays to improve fusion rates. Zimmer Biomet's portfolio includes knee and shoulder implants, while Johnson & Johnson focuses on advanced soft-tissue fixation devices. Medtronic's UNID rods and screws incorporate AI algorithms to optimize spinal alignment intraoperatively. Orthopedic devices development activity features OrthoPreserve's Defender meniscus replacement entering pivotal trials under FDA Breakthrough Device designation and Orthofix's AccelStim in post-approval studies. Key partnerships include licensing agreements for biomaterial coatings and co-development of sensor-enabled implants. Market positioning emphasizes value-based outcomes, with companies forging payor contracts that reward reduced revision rates. Recent milestones encompass FDA clearances (AccelStim May 2022, UNID June 2021), AAOS product launches (Insignia March 2022), and strategic collaborations in 3D-printed implant manufacturing. Commercial arrangements involve joint ventures in emerging markets to enhance distribution networks. Collectively, these efforts define a competitive environment focused on enhancing patient outcomes, expanding indications, and driving long-term growth in the orthopedic devices landscape. Delve deeper into the major and specialised companies in the Orthopedic Devices market @ Orthopedic Devices Competitive Landscape. Conclusion The orthopedic devices market is poised for sustained expansion through 2030, driven by demographic imperatives, technological innovation, and a diversified competitive field. Strategic collaborations, regulatory breakthroughs, and evolving clinical practices will shape the future, ensuring that next-generation implants and support devices meet the growing global demand for improved musculoskeletal health. Table of Contents 1. Orthopedic Devices Market Report Introduction 2. Orthopedic Devices Market Executive Summary 3. Competitive Landscape 4. Regulatory Analysis 5. Orthopedic Devices Market Key Factors Analysis 6. Orthopedic Devices Market Porter's Five Forces Analysis 7. Orthopedic Devices Market Assessment 8. Orthopedic Devices Market Company and Product Profiles 9. KOL Views 10. Project Approach 11. About DelveInsight 12. Disclaimer & Contact Us About DelveInsight DelveInsight is a leading business consulting and market research company focused on the healthcare and life sciences sectors, providing comprehensive market intelligence, competitive landscape analysis, and strategic insights to support decision-making across the pharmaceutical industry. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Arpit Anand Email: Send Email Phone: +14699457679 Address: 304 S. Jones Blvd #2432 City: Las Vegas State: Nevada Country: United States Website:
